Prothrombin, factor V Lieden, and methylene tetrahydrofolate reductase (MTHFR) gene polymorphisms as risk factors of preeclampsia in Alexandria, Egypt

被引：0
|
作者：
Galal, A. F.
Eldin, M. Z.
Mokhtar, M.
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
[2] Dept Reprod & Fertil Ctr, Colorado Springs, CO USA
[3] Univ Alexandria, Alexandria, Egypt
[4] Univ Kansas, Lawrence, KS 66045 USA
[5] High Inst Res, Cairo, Egypt
来源：
FERTILITY AND STERILITY | 2008年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P2
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 50 条
  • [41] The mutation Ala677->Val in the methylene tetrahydrofolate reductase gene: A risk factor for premature arterial disease and venous thrombosis
    Arruda, VR
    vonZuben, PM
    Chiaparini, LC
    AnnichinoBizzacchi, JM
    Costa, FF
    BLOOD, 1996, 88 (10) : 1128 - 1128
  • [42] Factor V G1691A and factor II G20210A transition and Ala677→Val in the methylene tetrahydrofolate reductase (MTHFR) are not associated with antiphospholipid syndrome (APS)
    Torrezan, MZ
    Arruda, VR
    Ozelo, MC
    Annichino-Bizzacchi, JM
    THROMBOSIS AND HAEMOSTASIS, 1999, : 769 - 769
  • [43] A single-nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy
    Mak, Raymond H.
    Alexander, Brian M.
    Asomaning, Kofi
    Heist, Rebecca S.
    Liu, Chen-yu
    Su, Li
    Zhai, Rihong
    Ancukiewicz, Marek
    Napolitano, Brian
    Niemierko, Andrzej
    Willers, Henning
    Choi, Noah C.
    Christiani, David C.
    CANCER, 2012, 118 (14) : 3654 - 3665
  • [44] Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations
    DeSancho, Maria Teresa
    Berlus, Nickisha
    Christos, Paul J.
    Rand, Jacob
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (01) : 11 - 15
  • [45] Role of Polymorphisms in Factor V (FV Leiden), Prothrombin, Plasminogen Activator Inhibitor Type-1 (PAI-1), Methylenetetrahydrofolate Reductase (MTHFR) and Cystathionine β-Synthase (CBS) Genes as Risk Factors for Thrombophilias
    Miranda-Vilela, A. L.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (10) : 997 - 1006
  • [46] Evaluation of the glycoprotein 1A (GP1a) 807TT, the methylene tetrahydrofolate reductase (MTHFR) 677TT, and the prothrombin 20210GA genotypes as cooperative risk factors for venous thrombosis among factor V 1691GA (Leiden) carriers.
    Hessner, MJ
    Dinauer, DM
    Luhm, RA
    Endres, JL
    Montgomery, RR
    Friedman, KD
    BLOOD, 1998, 92 (10) : 304A - 304A
  • [47] Factor V Leiden (FVL), prothrombin, MTHFR and PAI-1 polymorphisms and cancer risk in women; the Jerusalem perinatal study (JPS)
    Tiram, E.
    Friedlander, Y.
    Kadouri, L.
    Manor, O.
    Isacson, R.
    Yanetz, R.
    Deutsch, L.
    Harlap, S.
    Pattiel, O.
    THROMBOSIS RESEARCH, 2007, 120 : S176 - S177
  • [48] The C677 mutation in methylene tetrahydrofolate reductase gene: Correlation with uric acid and cardiovascular risk factors in elderly Korean men
    Hong, YS
    Lee, MJ
    Kim, KH
    Lee, SH
    Lee, YH
    Kim, BG
    Jeong, B
    Yoon, HR
    Nishio, H
    Kim, JY
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2004, 19 (02) : 209 - 213
  • [49] Factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms and the risk of tamoxifen-associated thromboembolism in breast cancer patients
    Eroglu, Aydan
    Akar, Nejat
    THROMBOSIS RESEARCH, 2011, 127 (04) : 384 - 385
  • [50] Methylene tetrahydrofolate reductase (MTHFR) gene rs1801133 C>T polymorphisms and response to 5-FU based chemotherapy in patients with colorectal cancer: a meta-analysis
    Jiang, Huafeng
    Shen, Yi
    PTERIDINES, 2019, 30 (01) : 126 - 132
12345